PHARMACCINES FOR LIFE
DEAD

Serial Number

78090586

Owner

PHARMEXA A/S

Attorney

CYNTHIA CLARKE WEBER

Filing Date

Oct 29, 2001

Add to watchlist:

No watchlists yet
View on USPTO

PHARMACCINES FOR LIFE Trademark

Serial Number: 78090586

PHARMACCINES FOR LIFE is a trademark filed by PHARMEXA A/S on October 29, 2001. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

PHARMEXA A/S (6 trademarks)

KOGLE ALLE 6
DK-2970 HORSHOLM , DK

Entity Type: 16

Trademark Details

Filing Date

October 29, 2001

Registration Date

Not Registered

Published for Opposition

October 1, 2002

Goods & Services

Pharmaceutical preparations and substances for the treatment of neoplastic disorders, inflammatory disorders, infectious diseases, traumatic disorders, metabolic disorders, hematologic respiratory disorders, vascular and cardial disorders, endocrinologic disorders, muscular disorders, skeletal and bone disorders, neurological disorders, skin and mucosal disorders, psychiatric disorders, lymphatic disorders, intestinal disorders, urologic disorders, and reproductive disorders; vaccines, namely, therapeutic vaccines, subcomponent vaccines, polypeptide vaccines, live vaccines, viral vaccines, nucleic acid vaccines and DNA vaccines, vaccine excipients, vaccine carriers, vaccines adjuvants; vaccines containing non-pathogenic microorganisms and vira; vaccines containing polypeptides, protein and nucleic acids, including DNA; 00

Chemical products for use in the development of pharmaceuticals, vaccines, namely therapeutic, subcomponent, polypeptide and live vaccines, viral and nucleic acids vaccines, DNA vaccines, vaccine excipients, vaccine carriers, and vaccine adjuvants for medical science; chemical preparations for analyses in laboratories for in vivo analyses for medical purposes; non-pathogenic microorganisms and vira for vaccine use, polypeptides, protein and nucleic acids, including DNA for vaccine use

Scientific, industrial biotechnological and biomedical research; pharmaceutical, biomedical and biotechnological development of therapeutic vaccines, other vaccines and pharmaceuticals; chemical, biochemical and molecular biological analyses; medical and scientific research, namely in vitro and in vivo preclinical tests of potential drugs; medical and scientific research, namely in vitro and in vivo research concerning therapeutic vaccines, other vaccines and potential drugs; scientific, industrial biotechnological and biomedical consultancy concerning the above analyses, tests and research; biomedical and pharmaceutical clinical testing and research

Filing History

ABANDONMENT - NO USE STATEMENT FILED
Sep 15, 2003 ABN6
NOA MAILED - SOU REQUIRED FROM APPLICANT
Dec 24, 2002 NOAM
PUBLISHED FOR OPPOSITION
Oct 1, 2002 PUBO
NOTICE OF PUBLICATION
Sep 11, 2002 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 16, 2002 CNSA
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 25, 2002 CRFA
PAPER RECEIVED
Jun 25, 2002 MAIL
NON-FINAL ACTION MAILED
Jan 28, 2002 CNRT
ASSIGNED TO EXAMINER
Jan 25, 2002 DOCK